Taroh Kinoshita

Q: What Schools Are Affiliated With Taroh Kinoshita

Taroh Kinoshita is affiliated with the following schools: Washington University in St. Louis, Uppsala University, University of Tokyo, Institute of Science Tokyo, Osaka University, Wakayama Medical University, Uniformed Services University of the Health Sciences, Kyoto University

Taroh Kinoshita's AcademicInfluence.com Rankings

Taroh Kinoshita

Computer Science

#6300

World Rank

#6646

Historical Rank

Machine Learning

#1998

World Rank

#2024

Historical Rank

Artificial Intelligence

#2248

World Rank

#2286

Historical Rank

Database

#3399

World Rank

#3540

Historical Rank

computer-science Degrees

Download Badge

Computer Science

Taroh Kinoshita's Degrees

PhD Computer Science University of Tokyo
Masters Computer Science Kyoto University
Bachelors Computer Science Kyoto University

Similar Degrees You Can Earn

Why Is Taroh Kinoshita Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Taroh Kinoshita's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria (1993) (954)
Diagnosis and management of paroxysmal nocturnal hemoglobinuria. (2005) (705)
Symbol Nomenclature for Graphical Representations of Glycans. (2015) (693)
Direct recognition of the mycobacterial glycolipid, trehalose dimycolate, by C-type lectin Mincle (2009) (639)
The cloning of PIG-A, a component in the early step of GPI-anchor biosynthesis. (1993) (495)
beta 2-Microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis. (1993) (408)
Distribution of decay-accelerating factor in the peripheral blood of normal individuals and patients with paroxysmal nocturnal hemoglobinuria (1985) (361)
Identity-by-descent filtering of exome sequence data identifies PIGV mutations in hyperphosphatasia mental retardation syndrome (2010) (301)
Tissue-specific knockout of the mouse Pig-a gene reveals important roles for GPI-anchored proteins in skin development. (1997) (266)
Biosynthesis, remodelling and functions of mammalian GPI-anchored proteins: recent progress. (2008) (263)
A beneficial role of bile pigments as an endogenous tissue protector: anti-complement effects of biliverdin and conjugated bilirubin. (1993) (262)
Defective stratum corneum and early neonatal death in mice lacking the gene for transglutaminase 1 (keratinocyte transglutaminase). (1998) (251)
Mouse complement regulatory protein Crry/p65 uses the specific mechanisms of both human decay-accelerating factor and membrane cofactor protein (1995) (242)
Mapping of epitopes, glycosylation sites, and complement regulatory domains in human decay accelerating factor. (1992) (236)
In vivo inhibition of the antibody response by a complement receptor- specific monoclonal antibody (1990) (234)
Clinical Course and Flow Cytometric Analysis of Paroxysmal Nocturnal Hemoglobinuria in the United States and Japan (2004) (224)
Clinical whole-genome sequencing in severe early-onset epilepsy reveals new genes and improves molecular diagnosis (2014) (218)
Glycosylphosphatidylinositol-anchor-deficient mice: implications for clonal dominance of mutant cells in paroxysmal nocturnal hemoglobinuria. (1996) (217)
Angiotensin-converting enzyme is a GPI-anchored protein releasing factor crucial for fertilization (2005) (214)
Biology of complement: the overture. (1991) (204)
Hypomorphic promoter mutation in PIGM causes inherited glycosylphosphatidylinositol deficiency (2006) (198)
Dissecting and manipulating the pathway for glycosylphos-phatidylinositol-anchor biosynthesis. (2000) (194)
Paroxysmal nocturnal haemoglobinuria (2017) (190)
GPI-anchor remodeling: potential functions of GPI-anchors in intracellular trafficking and membrane dynamics. (2012) (186)
Genetic variants in C5 and poor response to eculizumab. (2014) (185)
Fatty acid remodeling of GPI-anchored proteins is required for their raft association. (2007) (184)
Hypoxia/reoxygenation-mediated induction of astrocyte interleukin 6: a paracrine mechanism potentially enhancing neuron survival (1994) (184)
Monoclonal antibodies to mouse complement receptor type 1 (CR1). Their use in a distribution study showing that mouse erythrocytes and platelets are CR1-negative. (1988) (179)
Biosynthesis of GPI-anchored proteins: special emphasis on GPI lipid remodeling (2016) (177)
Critical roles of glycosylphosphatidylinositol for Trypanosoma brucei. (2000) (171)
Developmental abnormalities of glycosylphosphatidylinositol-anchor-deficient embryos revealed by Cre/loxP system. (1999) (170)
A molecular and immunochemical characterization of mouse CR2. Evidence for a single gene model of mouse complement receptors 1 and 2. (1990) (170)
GPHR is a novel anion channel critical for acidification and functions of the Golgi apparatus (2008) (163)
Inositol Deacylation of Glycosylphosphatidylinositol-anchored Proteins Is Mediated by Mammalian PGAP1 and Yeast Bst1p* (2004) (155)
Molecular basis of clonal expansion of hematopoiesis in 2 patients with paroxysmal nocturnal hemoglobinuria (PNH). (2006) (151)
Distinct receptor and regulatory properties of recombinant mouse complement receptor 1 (CR1) and Crry, the two genetic homologues of human CR1 (1992) (150)
The evolution of mouse and human complement C3-binding proteins: divergence of form but conservation of function. (1992) (140)
Defective glycosyl phosphatidylinositol anchor synthesis and paroxysmal nocturnal hemoglobinuria. (1995) (136)
GPI-anchor synthesis in mammalian cells: genes, their products, and a deficiency. (1997) (135)
GPI-anchor biosynthesis. (1995) (134)
Mutations in PIGO, a member of the GPI-anchor-synthesis pathway, cause hyperphosphatasia with mental retardation. (2012) (134)
Expression Cloning of PIG-L, a CandidateN-Acetylglucosaminyl-phosphatidylinositol Deacetylase* (1997) (133)
Handbook of Glycosyltransferases and Related Genes (2014) (132)
GPI Glycan Remodeling by PGAP5 Regulates Transport of GPI-Anchored Proteins from the ER to the Golgi (2009) (129)
PimE Is a Polyprenol-phosphate-mannose-dependent Mannosyltransferase That Transfers the Fifth Mannose of Phosphatidylinositol Mannoside in Mycobacteria* (2006) (127)
Gaa1p and gpi8p are components of a glycosylphosphatidylinositol (GPI) transamidase that mediates attachment of GPI to proteins. (2000) (127)
PIG‐B, a membrane protein of the endoplasmic reticulum with a large lumenal domain, is involved in transferring the third mannose of the GPI anchor. (1996) (126)
Decay-accelerating factor is present on cultured human umbilical vein endothelial cells (1986) (122)
Modulation of mouse complement receptors 1 and 2 suppresses antibody responses in vivo. (1991) (122)
Biosynthesis and deficiencies of glycosylphosphatidylinositol (2014) (117)
PGAP2 is essential for correct processing and stable expression of GPI-anchored proteins. (2005) (116)
Requirement of N‐glycan on GPI‐anchored proteins for efficient binding of aerolysin but not Clostridium septicum α‐toxin (2002) (115)
Region-specific saturation germline mutagenesis in mice using the Sleeping Beauty transposon system (2005) (114)
Amelioration of lytic abnormalities of paroxysmal nocturnal hemoglobinuria with decay-accelerating factor. (1985) (113)
Sorting of GPI-anchored proteins into ER exit sites by p24 proteins is dependent on remodeled GPI (2011) (112)
Prostacyclin-Deficient Mice Develop Ischemic Renal Disorders, Including Nephrosclerosis and Renal Infarction (2002) (111)
Human PIG-U and yeast Cdc91p are the fifth subunit of GPI transamidase that attaches GPI-anchors to proteins. (2003) (110)
Structural remodeling of GPI anchors during biosynthesis and after attachment to proteins (2010) (109)
Biosynthesis and biology of mammalian GPI-anchored proteins (2019) (109)
Structural remodeling, trafficking and functions of glycosylphosphatidylinositol-anchored proteins. (2011) (106)
Molecular cloning of murine pig-a, a gene for GPI-anchor biosynthesis, and demonstration of interspecies conservation of its structure, function, and genetic locus. (1994) (105)
Antibodies to murine complement receptor 1 and 2 can inhibit the antibody response in vivo without inhibiting T helper cell induction. (1995) (104)
Critical Roles for Lipomannan and Lipoarabinomannan in Cell Wall Integrity of Mycobacteria and Pathogenesis of Tuberculosis (2013) (103)
A novel glycosylphosphatidyl inositol-anchored protein on human leukocytes: a possible role for regulation of neutrophil adherence and migration. (1999) (101)
An anticomplementary agent, K-76 monocarboxylic acid: its site and mechanism of inhibition of the complement activation cascade. (1979) (100)
PGAP2 mutations, affecting the GPI-anchor-synthesis pathway, cause hyperphosphatasia with mental retardation syndrome. (2013) (100)
C5 convertase of the alternative complement pathway: covalent linkage between two C3b molecules within the trimolecular complex enzyme. (1988) (98)
PIG-W is critical for inositol acylation but not for flipping of glycosylphosphatidylinositol-anchor. (2003) (96)
Mutations in PGAP3 impair GPI-anchor maturation, causing a subtype of hyperphosphatasia with mental retardation. (2014) (95)
Hypomorphic mutations in PGAP2, encoding a GPI-anchor-remodeling protein, cause autosomal-recessive intellectual disability. (2013) (94)
Covalent association of C3b with C4b within C5 convertase of the classical complement pathway (1987) (92)
Dolichol-phosphate mannose synthase: structure, function and regulation. (2008) (92)
Cross-talk between Caveolae and Glycosylphosphatidylinositol-rich Domains* (2001) (91)
Glycosylphosphatidylinositol (GPI) anchor deficiency caused by mutations in PIGW is associated with West syndrome and hyperphosphatasia with mental retardation syndrome (2013) (91)
Mammalian GPI-anchored proteins require p24 proteins for their efficient transport from the ER to the plasma membrane. (2008) (89)
Analysis of Epstein-Barr virus-binding sites on complement receptor 2 (CR2/CD21) using human-mouse chimeras and peptides. At least two distinct sites are necessary for ligand-receptor interaction. (1991) (88)
PIG-A and PIG-H, Which Participate in Glycosylphosphatidylinositol Anchor Biosynthesis, Form a Protein Complex in the Endoplasmic Reticulum* (1996) (88)
Mechanism for Release of Alkaline Phosphatase Caused by Glycosylphosphatidylinositol Deficiency in Patients with Hyperphosphatasia Mental Retardation Syndrome* (2012) (86)
Mammalian PIG-L and its yeast homologue Gpi12p are N-acetylglucosaminylphosphatidylinositol de-N-acetylases essential in glycosylphosphatidylinositol biosynthesis. (1999) (86)
Surface Sialic Acids Taken from the Host Allow Trypanosome Survival in Tsetse Fly Vectors (2004) (86)
Association of dengue virus NS1 protein with lipid rafts. (2008) (85)
Cloning of a human gene, PIG-F, a component of glycosylphosphatidylinositol anchor biosynthesis, by a novel expression cloning strategy. (1993) (82)
Targeted therapy for inherited GPI deficiency. (2007) (81)
Post-Golgi anterograde transport requires GARP-dependent endosome-to-TGN retrograde transport (2015) (81)
Requirement of PIG-F and PIG-O for Transferring Phosphoethanolamine to the Third Mannose in Glycosylphosphatidylinositol* (2000) (80)
Saccharomyces cerevisiae GPI10, the functional homologue of human PIG-B, is required for glycosylphosphatidylinositol-anchor synthesis. (1998) (80)
Analysis of C3b/C3d binding sites and factor I cofactor regions within mouse complement receptors 1 and 2. (1994) (79)
A case of paroxysmal nocturnal hemoglobinuria caused by a germline mutation and a somatic mutation in PIGT. (2013) (79)
Genome-wide phenotype analysis in ES cells by regulated disruption of Bloom's syndrome gene (2004) (79)
PIG-C, one of the three human genes involved in the first step of glycosylphosphatidylinositol biosynthesis is a homologue of Saccharomyces cerevisiae GPI2. (1996) (79)
Characterization of murine complement receptor type 2 and its immunological cross-reactivity with type 1 receptor. (1990) (78)
Relationship between decay accelerating factor deficiency, diminished acetylcholinesterase activity, and defective terminal complement pathway restriction in paroxysmal nocturnal hemoglobinuria erythrocytes. (1987) (78)
The biological roles of the third component of complement in osteoclast formation. (1993) (78)
PGAP1 Knock-out Mice Show Otocephaly and Male Infertility* (2007) (76)
PIG-V Involved in Transferring the Second Mannose in Glycosylphosphatidylinositol* (2005) (76)
Endogenous association of decay-accelerating factor (DAF) with C4b and C3b on cell membranes. (1986) (75)
Two Subunits of Glycosylphosphatidylinositol Transamidase, GPI8 and PIG-T, Form a Functionally Important Intermolecular Disulfide Bridge* (2003) (75)
Pathogenic Variants in PIGG Cause Intellectual Disability with Seizures and Hypotonia. (2016) (74)
Mammalian PIG-X and yeast Pbn1p are the essential components of glycosylphosphatidylinositol-mannosyltransferase I. (2005) (72)
Inefficient response of T lymphocytes to glycosylphosphatidylinositol anchor-negative cells: implications for paroxysmal nocturnal hemoglobinuria. (2002) (71)
A Complement Inhibitor Produced by Stachybotrys complementi, nov. sp. K‐76, a New Species of Fungi Imperfecti (1980) (71)
Role of TraT protein, an anticomplementary protein produced in Escherichia coli by R100 factor, in serum resistance. (1992) (70)
Vitamin B6–responsive epilepsy due to inherited GPI deficiency (2013) (70)
Null Mutation in PGAP1 Impairing Gpi-Anchor Maturation in Patients with Intellectual Disability and Encephalopathy (2014) (70)
Mutations in PIGY: expanding the phenotype of inherited glycosylphosphatidylinositol deficiencies (2015) (68)
Genome-Wide Screening Uncovers the Significance of N-Sulfation of Heparan Sulfate as a Host Cell Factor for Chikungunya Virus Infection (2017) (68)
Covalent binding of C3b to C4b within the classical complement pathway C5 convertase. Determination of amino acid residues involved in ester linkage formation. (1992) (61)
Inositol lipid metabolism in mycobacteria: biosynthesis and regulatory mechanisms. (2011) (61)
Novel compound heterozygous PIGT mutations caused multiple congenital anomalies-hypotonia-seizures syndrome 3 (2014) (60)
Enhanced humoral immune responses against T-independent antigens in Fcα/μR-deficient mice (2009) (58)
GPI7 Is the Second Partner of PIG-F and Involved in Modification of Glycosylphosphatidylinositol* (2005) (58)
A Homologue of Saccharomyces cerevisiae Dpm1p Is Not Sufficient for Synthesis of Dolichol-Phosphate-Mannose in Mammalian Cells* (1998) (58)
GPI transamidase of Trypanosoma brucei has two previously uncharacterized (trypanosomatid transamidase 1 and 2) and three common subunits (2003) (58)
Spatially distinct and metabolically active membrane domain in mycobacteria (2016) (57)
PIGN mutations cause congenital anomalies, developmental delay, hypotonia, epilepsy, and progressive cerebellar atrophy (2014) (57)
Safety and efficacy of the terminal complement inhibitor eculizumab in Japanese patients with paroxysmal nocturnal hemoglobinuria: the AEGIS Clinical Trial (2011) (56)
Inhibition of immunological memory and T‐independent humoral responses by monoclonal antibodies specific for murine complement receptors (1991) (56)
Acquisition of Complement Resistance through Incorporation of CD55/Decay-Accelerating Factor into Viral Particles Bearing Baculovirus GP64 (2010) (55)
The initial enzyme for glycosylphosphatidylinositol biosynthesis requires PIG-Y, a seventh component. (2005) (55)
Phylogeny of the third component of complement, C3: analysis of the conservation of human CR1, CR2, H, and B binding sites, concanavalin A binding sites, and thiolester bond in the C3 from different species. (1992) (54)
Integrin-linked kinase associated with integrin activation. (2009) (53)
Efficacy of recombinant bacille Calmette-Guérin vaccine secreting interleukin-15/antigen 85B fusion protein in providing protection against Mycobacterium tuberculosis. (2008) (53)
Characterization of a complement receptor 2 (CR2, CD21) ligand binding site for C3. An initial model of ligand interaction with two linked short consensus repeat modules. (1995) (53)
Release of phospholipids from complement-mediated lesions on the surface structure of Escherichia coli. (1977) (52)
DPM1, the Catalytic Subunit of Dolichol-phosphate Mannose Synthase, Is Tethered to and Stabilized on the Endoplasmic Reticulum Membrane by DPM3* (2006) (51)
Inhibitory effect of K-76 monocarboxylic acid, an anticomplementary agent, on the C3b inactivator system. (1981) (50)
Molecular Genetics of Paroxysmal Nocturnal Hemoglobinuria (2003) (49)
CD59‐deficient blood cells and PIG‐A gene abnormalities in Japanese patients with aplastic anaemia (1999) (49)
Changes in molecular species profiles of glycosylphosphatidylinositol anchor precursors in early stages of biosynthesis Published, JLR Papers in Press, April 20, 2007. (2007) (47)
The glycan core of GPI‐anchored proteins modulates aerolysin binding but is not sufficient: the polypeptide moiety is required for the toxin–receptor interaction (2002) (47)
Mutations in GPAA1, Encoding a GPI Transamidase Complex Protein, Cause Developmental Delay, Epilepsy, Cerebellar Atrophy, and Osteopenia. (2017) (46)
Controlled Expression of Branch-forming Mannosyltransferase Is Critical for Mycobacterial Lipoarabinomannan Biosynthesis (2010) (46)
Lipoarabinomannan binding to lactosylceramide in lipid rafts is essential for the phagocytosis of mycobacteria by human neutrophils (2016) (45)
Structural Requirements for the Recruitment of Gaa1 into a Functional Glycosylphosphatidylinositol Transamidase Complex* (2002) (45)
Transgenic pigs expressing human decay‐accelerating factor regulated by porcine MCP gene promoter (2002) (45)
Peroxisome dependency of alkyl-containing GPI-anchor biosynthesis in the endoplasmic reticulum (2009) (44)
Relationship Between Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria (2002) (44)
Decreased susceptibility of leukemic cells with PIG-A mutation to natural killer cells in vitro. (2002) (43)
Altered T cell development in human thymoma is related to impairment of MHC class II transactivator expression induced by interferon‐gamma (IFN‐γ) (2000) (42)
Regulatory proteins for the activated third and fourth components of complement (C3b and C4b) in mice. II. Identification and properties of complement receptor type 1 (CR1). (1985) (42)
Kola acuminata proanthocyanidins: a class of anti-trypanosomal compounds effective against Trypanosoma brucei. (2005) (42)
Mutations in PIGS, Encoding a GPI Transamidase, Cause a Neurological Syndrome Ranging from Fetal Akinesia to Epileptic Encephalopathy. (2018) (42)
CHO glycosylation mutants: GPI anchor. (2006) (42)
N-Glycan–dependent protein folding and endoplasmic reticulum retention regulate GPI-anchor processing (2018) (40)
Mutations in the phosphatidylinositol glycan C (PIGC) gene are associated with epilepsy and intellectual disability (2016) (40)
Monkeypox Virus Host Factor Screen Using Haploid Cells Identifies Essential Role of GARP Complex in Extracellular Virus Formation (2017) (40)
Inhibition of immune precipitation by complement. (1984) (40)
Compound heterozygous mutations in the gene PIGP are associated with early infantile epileptic encephalopathy (2017) (38)
GPI1 Stabilizes an Enzyme Essential in the First Step of Glycosylphosphatidylinositol Biosynthesis* (1999) (38)
Essentials of Glycobiology [Internet] (2015) (38)
The acidic environment of the Golgi is critical for glycosylation and transport. (2010) (38)
Glycosylphosphatidylinositol (GPI) Anchors: Biochemistry and Cell Biology: Introduction to a Thematic Review Series (2016) (37)
Evidence for a one-hit theory in the immune bactericidal reaction and demonstration of a multi-hit response for hemolysis by streptolysin O and Clostridium perfringens theta-toxin (1976) (37)
Its8, a Fission Yeast Homolog of Mcd4 and Pig-n, Is Involved in GPI Anchor Synthesis and Shares an Essential Function with Calcineurin in Cytokinesis* (2001) (36)
Preferential inactivation of the C5 convertase of the alternative complement pathway by factor I and membrane cofactor protein (MCP). (1991) (36)
Rare Noncoding Mutations Extend the Mutational Spectrum in the PGAP3 Subtype of Hyperphosphatasia with Mental Retardation Syndrome (2016) (36)
Implications of lipid moiety in oligomerization and immunoreactivities of GPI-anchored proteins (2013) (35)
PIGO mutations in intractable epilepsy and severe developmental delay with mild elevation of alkaline phosphatase levels (2014) (35)
Role of phosphatidylinositol-linked proteins in paroxysmal nocturnal hemoglobinuria pathogenesis. (1996) (35)
Mutations in PIGB Cause an Inherited GPI Biosynthesis Defect with an Axonal Neuropathy and Metabolic Abnormality in Severe Cases. (2019) (35)
Long-term support of hematopoiesis by a single stem cell clone in patients with paroxysmal nocturnal hemoglobinuria. (2002) (35)
Localization of the covalent C3b-binding site on C4b within the complement classical pathway C5 convertase, C4b2a3b. (1990) (35)
Transport of glycosylphosphatidylinositol-anchored proteins from the endoplasmic reticulum. (2013) (34)
Genetic Disorders of Glycan Degradation (2009) (33)
Deregulated expression of HMGA2 is implicated in clonal expansion of PIGA deficient cells in paroxysmal nocturnal haemoglobinuria (2012) (33)
Identification of a Golgi GPI-N-acetylgalactosamine transferase with tandem transmembrane regions in the catalytic domain (2018) (32)
Mutations in PIGU Impair the Function of the GPI Transamidase Complex, Causing Severe Intellectual Disability, Epilepsy, and Brain Anomalies. (2019) (32)
Reconstitution of C5 convertase of the alternative complement pathway with isolated C3b dimer and factors B and D. (1991) (31)
Mutations in PIGL in a patient with Mabry syndrome (2015) (31)
Biogenesis of GPI-anchored proteins is essential for surface expression of sodium channels in zebrafish Rohon-Beard neurons to respond to mechanosensory stimulation (2010) (31)
Significance of Glycosylphosphatidylinositol-anchored Protein Enrichment in Lipid Rafts for the Control of Autoimmunity* (2013) (30)
Inhibition of the alternative C3 convertase and classical C5 convertase of complement by group A streptococcal M protein (1990) (29)
Effects of K-76 monocarboxylic acid, an anticomplementary agent, on various in vivo immunological reactions and on experimental glomerulonephritis. (1984) (29)
A GPI processing phospholipase A2, PGAP6, modulates Nodal signaling in embryos by shedding CRIPTO (2016) (29)
Different membrane anchors of Fc gamma RIII (CD16) on K/NK-lymphocytes and neutrophils. Protein- vs lipid-anchor. (1989) (28)
Cross-talks of glycosylphosphatidylinositol biosynthesis with glycosphingolipid biosynthesis and ER-associated degradation (2019) (28)
Molecular cloning of a pig homologue of membrane cofactor protein (CD46). (1997) (28)
Interim analysis of post-marketing surveillance of eculizumab for paroxysmal nocturnal hemoglobinuria in Japan (2016) (28)
Trypanosome glycosylphosphatidylinositol biosynthesis. (2009) (27)
Complement and inflammasome overactivation mediates paroxysmal nocturnal hemoglobinuria with autoinflammation. (2019) (27)
The α-Helical Region in p24γ2 Subunit of p24 Protein Cargo Receptor Is Pivotal for the Recognition and Transport of Glycosylphosphatidylinositol-anchored Proteins* (2014) (27)
Release of phospholipids from liposomal model membrane damaged by antibody and complement. (1977) (26)
Enzymatic mechanism of GPI anchor attachment clarified (2014) (26)
Analysis of PIG‐A gene in a patient who developed reciprocal translocation of chromosome 12 and paroxysmal nocturnal hemoglobinuria during follow‐up of aplastic anemia (1996) (26)
Long-term efficacy and safety of eculizumab in Japanese patients with PNH: AEGIS trial (2013) (26)
Guideline for hereditary angioedema (HAE) 2010 by the Japanese Association for Complement Research - secondary publication. (2012) (25)
Ligand specificities of mouse complement receptor types 1 (CR1) and 2 (CR2) purified from spleen cells. (1993) (25)
Antibody binding to individual short consensus repeats of decay-accelerating factor enhances enterovirus cell attachment and infectivity. (1998) (24)
A cohort study of the nature of paroxysmal nocturnal hemoglobinuria clones and PIG‐A mutations in patients with aplastic anemia (2006) (24)
A novel PIGN mutation and prenatal diagnosis of inherited glycosylphosphatidylinositol deficiency (2016) (24)
Simple methods for preparing EAC1,4b,2a,3b and EAC4b,3b with human or guinea pig complement components using an anticomplementary agent, K-76 monocarboxylic acid. (1981) (24)
Regulatory proteins for the activated third and fourth components of complement (C3b and C4b) in mice. I. Isolation and characterization of factor H: the serum cofactor for the C3b/C4b inactivator (factor I). (1984) (23)
Stress-induced Synthesis of Phosphatidylinositol 3-Phosphate in Mycobacteria (2010) (23)
A high m.w. form of decay-accelerating factor (DAF-2) exhibits size abnormalities in paroxysmal nocturnal hemoglobinuria erythrocytes. (1987) (22)
A homozygous PIGN missense mutation in Soft-Coated Wheaten Terriers with a canine paroxysmal dyskinesia (2016) (22)
3D Structure and Interaction of p24β and p24δ Golgi Dynamics Domains: Implication for p24 Complex Formation and Cargo Transport. (2016) (22)
Erythrocyte surface glycosylphosphatidyl inositol anchored receptor for the malaria parasite. (2005) (22)
Free, unlinked glycosylphosphatidylinositols on mammalian cell surfaces revisited (2019) (22)
Defective lipid remodeling of GPI anchors in peroxisomal disorders, Zellweger syndrome, and rhizomelic chondrodysplasia punctata (2012) (22)
GPHR-dependent functions of the Golgi apparatus are essential for the formation of lamellar granules and the skin barrier. (2012) (21)
Bi-allelic Variants in the GPI Transamidase Subunit PIGK Cause a Neurodevelopmental Syndrome with Hypotonia, Cerebellar Atrophy, and Epilepsy. (2020) (21)
Epileptic apnea in a patient with inherited glycosylphosphatidylinositol anchor deficiency and PIGT mutations (2018) (21)
A novel mutation in PIGW causes glycosylphosphatidylinositol deficiency without hyperphosphatasia (2016) (20)
Glycosylphosphatidylinositol anchors regulate glycosphingolipid levels[S] (2012) (20)
Membrane-bound C4b interacts endogenously with complement receptor CR1 of human red cells (1986) (20)
Phenotype–genotype correlations of PIGO deficiency with variable phenotypes from infantile lethality to mild learning difficulties (2017) (20)
The GPI1 homologue from Plasmodium falciparum complements a Saccharomyces cerevisiae GPI1 anchoring mutant. (2002) (19)
Effect of trypsinization on the activity of human factor H. (1982) (19)
TbGPI16 is an essential component of GPI transamidase in Trypanosoma brucei (2006) (19)
Bactericidal activity of the normal, cell-free hemolymph of silkworms (Bombyx mori) (1977) (19)
Acetylcholinesterase and lymphocyte function-associated antigen 3 found on decay-accelerating factor-negative erythrocytes from some patients with paroxysmal nocturnal hemoglobinuria are lost during erythrocyte aging. (1990) (19)
Genome-Wide Screening of Genes Required for Glycosylphosphatidylinositol Biosynthesis (2015) (19)
Cloning and characterization of the murine GPI anchor synthesis gene Pigf, a homologue of the human PIGF gene. (1996) (19)
A homozygous variant disrupting the PIGH start‐codon is associated with developmental delay, epilepsy, and microcephaly (2018) (18)
Congenital Defects in the Expression of the Glycosylphosphatidylinositol-Anchored Complement Regulatory Proteins CD59 and Decay-Accelerating Factor. (2018) (17)
GPI-anchor synthesis. (1994) (17)
Removal or Maintenance of Inositol-linked Acyl Chain in Glycosylphosphatidylinositol Is Critical in Trypanosome Life Cycle* (2006) (17)
GPI-anchor deficiency in myeloid cells causes impaired FcgammaR effector functions. (2004) (17)
Simulation and estimation of gene number in a biological pathway using almost complete saturation mutagenesis screening of haploid mouse cells (2014) (16)
Enhanced response of T lymphocytes from Pgap3 knockout mouse: Insight into roles of fatty acid remodeling of GPI anchored proteins. (2012) (16)
Rapid and simple measurement of human C5a-des-Arg level in plasma or serum using monoclonal antibodies. (1987) (16)
Production of transgenic pigs expressing human DAF (CD55) regulated by the porcine MCP gene promoter. (2000) (15)
Structure and chromosomal localization of the GPI-anchor synthesis gene PIGF and its pseudogene psi PIGF. (1995) (15)
Both mammalian PIG-M and PIG-X are required for growth of GPI14-disrupted yeast. (2007) (15)
Acetylcholinesterase and Lymphocyte Function-Associated Antigen 3 Found on Decay-Accelerating Factor-Negative Erythrocytes From Some Patients With Paroxysmal Nocturnal Hemoglobinuria Are Lost During Erythrocyte Aging (1990) (15)
A monoclonal antibody against human decay-accelerating factor (DAF, CD55), D17, which lacks reactivity with semen-DAF. (1993) (15)
Cerebral visual impairment and intellectual disability caused by PGAP1 variants (2015) (14)
The low C5 convertase activity of the C4A6 allotype of human complement component C4. (1989) (14)
Lipid moiety of glycosylphosphatidylinositol‐anchored proteins contributes to the determination of their final destination in yeast (2018) (14)
PIGN prevents protein aggregation in the endoplasmic reticulum independently of its function in the GPI synthesis (2017) (14)
Intestinal absorption of riboflavin, studied by an in situ circulation system using radioactive analogues. (1988) (13)
Paroxysmal Nocturnal Hemoglobinuria (2012) (13)
Glycolipids with nonreducing end α‐mannosyl residues that have the potential to activate invariant Vα19 NKT cells (2007) (12)
THE PERIPHERAL BLOOD OF NORMAL INDIVIDUALS AND PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (1985) (12)
Structures and chromosomal localizations of the glycosylphosphatidylinositol synthesis gene PIGC and its pseudogene PIGCP1. (1997) (12)
Deficiency of complement decay-accelerating factor (DAF, CD55) in non-Hodgkin's lymphoma. (1991) (11)
Testicular Angiotensin-converting enzyme with different glycan modification: characterization on glycosylphosphatidylinositol-anchored protein releasing and dipeptidase activities. (2008) (11)
Interactions between murine B lymphocyte surface membrane molecules. Loaded but not free receptors for complement and the Fc portion of IgG co-cap independently with cross-linked surface Ig. (1990) (11)
Recurrent aseptic meningitis with PIGT mutations: a novel pathogenesis of recurrent meningitis successfully treated by eculizumab (2018) (11)
Glycosylphosphatidylinositol mannosyltransferase II is the rate-limiting enzyme in glycosylphosphatidylinositol biosynthesis under limited dolichol-phosphate mannose availability. (2013) (11)
Glycan region of GPI anchored-protein is required for cytocidal oligomerization of an anticancer parasporin-2, Cry46Aa1 protein, from Bacillus thuringiensis strain A1547. (2017) (10)
Inherited glycosylphosphatidylinositol defects cause the rare Emm-negative blood phenotype and developmental disorders. (2021) (10)
Enhanced Responses of Glycosylphosphatidylinositol Anchor-Deficient T Lymphocytes1 (2004) (10)
New insights into the functions of PIGF, a protein involved in the ethanolamine phosphate transfer steps of glycosylphosphatidylinositol biosynthesis. (2014) (9)
α2,3 linkage of sialic acid to a GPI anchor and an unpredicted GPI attachment site in human prion protein (2020) (9)
Bactericidal activity of C9-deficient human serum. (1992) (9)
Proteolytic elimination of decay-accelerating factor (DAF): lytic abnormality coincides with removal of DAF in papain-treated human erythrocytes. (1990) (9)
Nuclear envelope localization of PIG-B is essential for GPI-anchor synthesis in Drosophila (2017) (8)
Host Cell Protection from Complement by Glycosyl-phosphatidylinositol-Anchored Complement Inhibitors and Their Deficiencies in Paroxysmal Nocturnal Hemoglobinuria (1989) (8)
Cerebellar Neurodegeneration and Neuronal Circuit Remodeling in Golgi pH Regulator-Deficient Mice (2019) (8)
A post glycosylphosphatidylinositol (GPI) attachment to proteins, type 2 (PGAP2) variant identified in Mabry syndrome index cases: Molecular genetics of the prototypical inherited GPI disorder. (2019) (8)
Molecular remodelling of human CD46 for xenotransplantation: designing a potent complement regulator without measles virus receptor activity (2000) (8)
Structural changes of GPI anchor after its attachment to proteins: functional significance. (2015) (8)
Fluid-phase activation of the alternative pathway of complement by excess factor D in regularly dialyzed patients. (1992) (8)
Calnexin mediates the maturation of GPI-anchors through ER retention (2020) (8)
Impaired FcεRI stability, signaling, and effector functions in murine mast cells lacking glycosylphosphatidylinositol-anchored proteins. (2011) (8)
Identification of a second catalytically active trans-sialidase in Trypanosoma brucei. (2011) (8)
Expression cloning strategies for glycosylphosphatidylinositol-anchor biosynthesis enzymes and regulators. (1995) (8)
Early infancy-onset stimulation-induced myoclonic seizures in three siblings with inherited glycosylphosphatidylinositol (GPI) anchor deficiency. (2018) (7)
Fifth component of guinea pig complement: purification and characterization. (1981) (7)
GPI-anchor deficiency in myeloid cells causes impaired Fc R effector functions (2004) (7)
C9 hemolytic activity of the soluble C5b-9 complex of guinea pig complement, analogous to human SC5b-9. (1979) (7)
New mutant Chinese hamster ovary cell representing an unknown gene for attachment of glycosylphosphatidylinositol to proteins. (2005) (7)
PGAP6, a GPI-specific phospholipase A2, has narrow substrate specificity against GPI-anchored proteins (2020) (7)
Analysis of C 3 b / C 3 d Binding Sites and Factor I Cofactor Regions Within Mouse Complement Receptors 1 and 2 ' (2001) (6)
Occupancy of whole blood cells by a single PIGA‐mutant clone with HMGA2 amplification in a paroxysmal nocturnal haemoglobinuria patient having blood cells with NKG2D ligands (2013) (6)
Animal Models of PNH (2000) (6)
Number of Hits Necessary for Complement‐Mediated Hemolysis (1986) (6)
Designing sleeping sickness control. (2008) (5)
Human and mouse GPAA1 (Glycosylphosphatidylinositol anchor attachment 1) genes: genomic structures, chromosome loci and the presence of a minor class intron (1999) (5)
Crystallographic analysis of murine p24γ2 Golgi dynamics domain (2017) (5)
Paroxysmal nocturnal hemoglobinuria with copy number‐neutral 6pLOH in GPI (+) but not in GPI (−) granulocytes (2014) (5)
Paroxysmal nocturnal hemoglobinuria. (2012) (5)
Synthesis, Genetics, and Congenital Diseases of GPI-Anchored Proteins (2017) (5)
A Rare Genetic Polymorphism In C5 Confers Poor Response To The Anti-C5 Monoclonal Antibody Eculizumab In 11 Japanese Patients With PNH (2012) (5)
Molecular genetics, biochemistry, and biology of PNH. (2017) (4)
Porcine MCP gene promoter directs high level expression of human DAF (CD55) in transgenic mice. (2000) (4)
Isolation of new CHO cell mutants defective in CMP-sialic acid biosynthesis and transport. (2006) (4)
Biological Functions of Glycans -- Essentials of Glycobiology (2017) (4)
[Biosynthesis of GPI-anchored proteins]. (2003) (4)
Differentiation-Dependent Changes in Human Trophoblast Expression of Decay-Accelerating Factor Are Modulated by 3′,5′ Cyclic Adenosine Monophosphate (1997) (4)
Chronic Renal Insufficiency in Japanese Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH): Improvement with Eculizumab Treatment in the Long-Term Follow-up of the AEGIS Study. (2009) (4)
Protection of host from its own complement by membrane-bound complement inhibitors: C3 convertase inhibitors vs membrane attack complex inhibitors. (1996) (4)
Paroxysmal nocturnal hemoglobinuria and related disorders : molecular aspects of pathogenesis (2003) (4)
Oligosaccharides and Polysaccharides -- Essentials of Glycobiology (2017) (4)
Molecular basis of clonal expansion of hematopoiesis in two patients with paroxysmal nocturnal hemoglobinuria (PNH) Short title A mechanism of clonal expansion in PNH (2006) (3)
Glycolipids with nonreducing end alpha-mannosyl residues that have the potential to activate invariant Valpha19 NKT cells. (2007) (3)
Eighth component of guinea pig complement: purification and characterization. (1982) (3)
Symbol Nomenclature for Glycans (SNFG) (2016) (3)
Expression cloning of genes for GPI-anchor biosynthesis. (1994) (3)
Antibody feedback regulation in MRL/lpr mice. (1993) (3)
A Possible Intrinsic Mechanism for Clonal Expansion of PNH Abnormal Cells (2003) (3)
Paroxysmal nocturnal hemoglobinuria caused by CN-LOH of constitutional PIGB mutation and 70-kbp microdeletion on 15q. (2020) (3)
Eubacteria -- Essentials of Glycobiology (2017) (3)
Persistently high quality of life conferred by coexisting congenital deficiency of terminal complement C9 in a paroxysmal nocturnal hemoglobinuria patient. (2012) (2)
An Optimized Crovalimab Dose and Regimen Reduced the Formation of Drug-Target-Drug Complexes in Patients with Paroxysmal Nocturnal Hemoglobinuria from the Phase I/II COMPOSER Trial (2020) (2)
Glycomics and Glycoproteomics -- Essentials of Glycobiology (2017) (2)
[Inherited GPI deficiency; a new disease with intellectual disability and epilepsy]. (2015) (2)
Safety and Efficacy of the Terminal Complement Inhibitor Eculizumab in Japanese Patients with Paroxysmal Nocturnal Hemoglobinuria: AEGIS Phase II Clinical Study Results. (2008) (2)
4.21 – Diseases Associated with GPI Anchors (2007) (2)
Ethanolamine phosphate on the second mannose as bridge in GPI anchored proteins: Towards understanding inherited PIGG deficiency (2020) (2)
[Inherited GPI deficiencies:a new disease with intellectual disability and epilepsy]. (2015) (2)
Program and abstracts for the 2012 Joint Meeting of the Society for Glycobiology & American Society for Matrix Biology (2012) (2)
Paroxysmal Nocturnal Hemoglobinuria and Related Disorders (2003) (2)
Release of Phospholipids from Bacterial Surface Structure and Liposomes by the Action of Complement (1976) (2)
Chapter 1 Overview of GPI Biosynthesis (2009) (2)
TWO POSSIBLE MECHANISMS FOR ESCAPE OF GPI- CELLS FROM THE IMMUNOLOGICAL ATTACK (2003) (1)
Functional properties of the allotypes of mouse complement regulatory protein, factor H: difference of compatibility of each allotype with human factor I. (1993) (1)
Inflammatory defects caused by GPI-anchor deficiency in macrophages (2003) (1)
Archaea -- Essentials of Glycobiology (2017) (1)
One of the Three Human Genes Involved in the First Step of Glycosylphosphatidylinositol Biosynthesis Is a Homologue of Saccharomyces cerevisiae GPI 2 (1996) (1)
CLPTM1L is a lipid scramblase involved in glycosylphosphatidylinositol biosynthesis (2021) (1)
Clinical Effects of Eculizumab in PNH: Poor Responders to Eculizumab (2017) (1)
Human β2-Microglobulin Modified with Advanced Glycation End Products in Hemodialysis-Associated Amyloidosis (2005) (1)
Clonal Expansion in Paroxysmal Nocturnal Hemoglobinuria (PNH): Expression of Mutant HMGA2 Suggests That PNH Is a Benign Tumor of the Bone Marrow. (2005) (1)
Serial Analysis of Clonal Expansion in PNH by Flow Cytometry (2003) (1)
Review in translational hematology Diagnosis and management of paroxysmal nocturnal hemoglobinuria (2005) (1)
[GPI-anchored proteins and paroxysmal nocturnal hemoglobinuria]. (1993) (1)
Hrd1-dependent degradation of the unassembled PIGK subunit of the GPI transamidase complex. (2021) (1)
Targeted Molecular Therapy for Inherited Glycosylphosphatidylinositol Deficiency. (2006) (1)
1560 PREVENTION OF COMPLEMENT ACTIVATION ON CELLS BY DAF pathway (1984) (1)
[Biochemistry of glycosylphosphatidylinositol (GPI) anchored proteins]. (2014) (1)
Decay-Accelerating Factor (CD55) (1998) (1)
Pig-P, the fourth protein associated with Pig-A that is responsible for paroxysmal nocturnal hemoglobinuria (2000) (1)
GPI-GlcNAc Transferase: Complex of PIG-A, PIG-C, PIG-H, hGPI1, and PIG-P (2002) (1)
GAA1 recognizes the GPI anchor attachment signals and is complexed with GP18 to form a GPI transamidase (1998) (1)
Structural Biology of Glycan Recognition -- Essentials of Glycobiology (2017) (1)
[GPI biosynthetic pathway as a target for antiprotozoan drugs]. (2002) (1)
Glycosylation Engineering -- Essentials of Glycobiology (2017) (1)
Complement- and inflammasome-mediated autoinflammation-paroxysmal nocturnal hemoglobinuria (2019) (1)
Overview of Paroxysmal Nocturnal Hemoglobinuria: Molecular Genetics (2003) (1)
GPI Mannose Extension (PIGM, PIGV, PIGB, PIGZ) (2014) (1)
Glycans in Infection and Immunity (2019) (1)
[An autopsy case of thymic carcinoma producing various tumor markers and the examination of 222 autopsy cases of thymic malignant tumor in Japan]. (2000) (1)
Murine monoclonal anti-Ba antibody that enhances haemolytic activity of factor B. (1991) (1)
Glycosylphosphatidylinositol-N- Acetylglucosaminyltransferase (GPI-GlcNAc Transferase): A Complex Comprised of PIGA, PIGC, PIGH, PIGQ, PIGP, PIGY and DPM2 106 (2014) (1)
Congenital Disorders of Glycosylation: Glycosylphosphatidylinositol (GPI)-Related (2014) (1)
PIGF deficiency causes a phenotype overlapping with DOORS syndrome (2021) (1)
Soluble C5b-9 complex of guinea pig complement: demonstration of its heterogeneity and the mechanism of its C9 hemolytic activity as transfer of reversibly bound C9 molecules from the complex. (1981) (1)
Neutrophil Adherence and Migration Leukocytes: A Possible Role for Regulation of Inositol-Anchored Protein on Human A Novel Glycosylphosphatidyl (1999) (0)
Fatigue and impaired quality of life in patients with paroxysmal nocturnal hemoglobinuria (PNH) is associated with hemolysis, but not with anemia (2012) (0)
Myelo- and lympho-proliferative disorders (WS-035) Chairpersons: Nagahiro Minato, Gilbert Faure (2010) (0)
Mouse complement regulatory protein Crry/p65 encompasses functions of DAF and MCP (1993) (0)
[Paroxysmal nocturnal hemoglobinuria and complement regulatory factors]. (1995) (0)
Exploration of molecules involved in control of platelet integrin αIIbβ3 function using a random mutagenesis approach (2009) (0)
Long-term efficacy and safety of eculizumab in Japanese patients with PNH: AEGIS trial Yuzuru KanakuraKazuma OhyashikiTsutomu ShichishimaShinichiro Okamoto • Kiyoshi AndoHaruhiko NinomiyaTatsuya KawaguchiShinji NakaoHideki Nakakuma • Jun-ichi NishimuraTaroh KinoshitaCamille L. BedrosianKeiya OzawaMi (2013) (0)
PIGO variants in a boy with features of Mabry syndrome who also exhibits Fryns syndrome with peripheral neuropathy (2020) (0)
[Paroxysmal nocturnal hemoglobinuria and GPI-anchored membrane proteins]. (1991) (0)
Functional linkage between N-glycan and GPI-anchor on proteins in the ER (2017) (0)
Rohon-Beard (RB) neurons are primary sensory neurons in the embryonic spinal cord in lower vertebrates such as lamprey, teleosts (2010) (0)
Establishment of a comprehensive complement examination system for complement-related diseases by the Japanese Association for Complement Research (2016) (0)
Glycan-Mediated Protein Transport from the Endoplasmic Reticulum (2015) (0)
PIGT mutation and a somatic mutation in A case of paroxysmal nocturnal hemoglobinuria caused by a germline (2013) (0)
[Biosynthesis of the GPI anchor]. (1994) (0)
Paroxysmal nocturnal hemoglobinuria caused by PIGT mutations: Atypical PNH (2016) (0)
Key Point : A carrier of a deleterious splice site mutation in PIGT acquired a second hit in PIGT and developed PNH (2013) (0)
[Paroxysmal nocturnal hemoglobinuria]. (2000) (0)
Research in Japan Has Contributed to the Understanding of GPI Anchor Deficiency (2008) (0)
G 1 y c o s y 1 p hos p h a t i d y li nos i t o 1 -Anchor - Deficient Mice : Implications for Clonal Dominance of Mutant Cells in Paroxysmal Nocturnal Hemoglobinuria (1996) (0)
[New strategy in development of antibiotics: GPI biosynthesis as a target]. (2006) (0)
Fatty acid remodeling of GPI anchor in CD59 (2007) (0)
Paroxysmal Nocturnal Hemoglobinuria Caused By Pigt Mutations; Atypical PNH (2016) (0)
PGAP4, a multipass Golgi transmembrane protein, is a GPI-GalNAc transferase for generating GPI-anchor side chain (2015) (0)
Japan-Thailand Collaboration Research on Infectious Diseases: Promotion and Hurdles (2014) (0)
Crucial Role of Complement Receptor Type 1 On the Accumulation of Complement Component 3 On Erythrocytes in Patients with PNH Treated with Eculizumab (2012) (0)
Molecular Complete Remission of Clonal Hematopoiesis in Paroxysmal Nocturnal Hemoglobinuria (PNH) after Syngeneic Transplantation. (2006) (0)
Map 5: Biosynthetic Pathways of GPI-Anchor (2014) (0)
A new strategy to clone a gene involved in glycosylphosphatidylinositol anchor biosynthesis (1993) (0)
Roles of Protein GPI-Anchors in African Trypanosomes and Hosts (2003) (0)
Glycosylphosphatidylinositol-Anchored Protein Biosynthesis and Related Genes in Mammalian Cells (2008) (0)
The Glycosylphosphatidylinositol Anchor Regulates T Cell Antigen Receptor Induced IL-2 Production (2021) (0)
SLE and other connective tissue diseases (animal models) (PP-017) (2010) (0)
B3GALT4 transfers galactose to GPI-GalNAc side-branch (2017) (0)
killer cells in vitro Decreased susceptibility of leukemic cells with PIG-Amutation to natural (2013) (0)
Interaction of the Eighth Component of Guinea Pig Complement (C8) with the Membrane‐Bound C5b‐7 Complex (1983) (0)
hemoglobinuria negative cells: implications for paroxysmal nocturnal - anchor Inefficient response of T lymphocytes to glycosylphosphatidylinositol (2013) (0)
Animal Models of Paroxysmal Nocturnal Hemoglobinuria (2017) (0)
[Remodeling of GPI-anchored proteins]. (2008) (0)
Clinical impact of uncontrolled complement activity in Japanese non-transfused patients with paroxysmal nocturnal hemoglobinuria (2012) (0)
Anticorps monoclonal du facteur d'acceleration de la decomposition (fad), son procede de production et d'utilisation. (1986) (0)
Functional activity of porcine membrane cofactor protein(MCP) gene promoter in vitro (1998) (0)
Enterovirus Cell Attachment and Infectivity Repeats of Decay-Accelerating Factor Enhances Antibody Binding to Individual Short Consensus (1998) (0)
Disfin _ ct Receptor and Regulatory Properties of Recombinant Mouse Complement Receptor 1 ( CR 1 ) and Crry , the Two Genetic Homologues of Human CR (2003) (0)
GPI-Anchor : Update for Biosynthesis and Remodeling (0)
172 Targeted disruption of the transglutaminase 1 gene (1997) (0)
Long-Term Support of Human Hematopoiesis by a Single Stem Cell Clone (2003) (0)
161A point mutation in an Sp1 binding motif in the promoter of the mannosyltransferase-encoding PIG-M gene causes inherited glycosylphosphatidylinositol deficiency (2007) (0)
Erratum to: PIGN mutations cause congenital anomalies, developmental delay, hypotonia, epilepsy, and progressive cerebellar atrophy (2014) (0)
PIG-B, GPI-Man Transferase III, Man- (Ethanolaminephosphate)Man-GlcN- (Acy1)PI Mannosyltransferase (2002) (0)
[Immuno-bactericidal reaction and one-hit theory]. (1975) (0)
ENZYMES REQUIRED FOR BIOSYNTHESIS OF GPI-ANCHORED PROTEINS (2002) (0)
Corrigendum to “Kola acuminata proanthocyanidins: a class of anti-trypanosomal compounds effective against Trypanosoma brucei” [International Journal for Parasitology 35 (2005) 91–103] (2005) (0)
Examples of GPI-Anchored Proteins (2017) (0)
Determination of the breakpoints of a chromosomal translocation found in a patient with paroxysmal nocturnal hemoglobinuria (2001) (0)
BIOSYNTHESIS OF GPI ANCHOR : TOPICS FROM MA MMALIAN AND YEAST SYSTEMS (1999) (0)
Safety and efficacy of the terminal complement inhibitor eculizumab in Japanese patients with paroxysmal nocturnal hemoglobinuria: AEGIS Phase II clinical study results (2012) (0)
Phosphatidyl Inositol Glycan‐A (PIG‐A) Gene (2002) (0)
Inhibitory effect of the complement receptor-specific monoclonal antibody on the induced antibody response and the role of CD4+ and CD8+ T-cells in the rat to mouse xenotransplantation. (1993) (0)
Precursors of select GPI-anchored proteins positively regulate GPI biosynthesis under the control of ERAD (2021) (0)
[Host-pathogen interactions: parasites]. (2009) (0)
A human CD46 mutants as a complement regulator but not a measles virus receptor: lessons for xenotransplantation (1998) (0)
Partial correction of the lytic abnormalities of paroxysmal nocturnal hemoglobinuria cells with decay accelerating factor (1985) (0)
Expression of HMGA2 in Blood Cells from Patients with Paroxysmal Nocturnal Hemoglobinuria. (2008) (0)
THE GPI1 AND GPI8 HOMOLOGUES FROM PLASMODIUM FALCIPARUM COMPLEMENT SACCHAROMYCES CEREVISIAE GPI ANCHORING MUTANTS (2002) (0)
Biosynthesis of GPI-anchored proteins is essential for surface expression of sodium channels in zebrafish Rohon-Beard neurons to respond to mechanosensory stimulation (2010) (0)
Release of Alkaline Phosphatase Caused by PIGV Mutations In Patients with Hyperphosphatasia-Mental Retardation Syndrome (HPMR), a Recently Found Second Inherited GPI Anchor Deficiency. (2010) (0)
Inherited GPI-Anchor Deficiencies Caused By The Hypomorphic Mutations In PIG A gene: Comparison To Paroxysmal Nocturnal Hemogrobinuria (2013) (0)
Expression of HMGA2 in blood cells from patients with paroxysmal nocturnal haemoglobinuria (2008) (0)
An essential role for GPHR in cerebellar neurons (2017) (0)
Inflammasome (WS-078) Chairpersons: Shun'ichiro Taniguchi, Takashi Suda (2010) (0)
T Lymphocytes Glycosylphosphatidylinositol Anchor-Deficient Enhanced Responses of Nishimura (2004) (0)
Glycosylphosphatidylinositol (GPI)-anchor Biosynthesis (1999) (0)
GPI-N-acetylglucosaminyl transferase for the first step of glycosylphosphatidylinositol biosynthesis is mediated by protein complex composed of PIG-A, PIG-H, PIG-C and HGPI 1 (1997) (0)
Pathogenesis of Clonal Dominance in PNH: Growth Advantage in PNH (2017) (0)
(Running title) Inefficient response of T cells to GPI -anchor -negative cells (2002) (0)
BriefDefinitive Report In Vivo Inhibition of the Antibody Response by a Complement Receptor-Specific Monoclonal Antibody (2003) (0)
[Recent advances in research on paroxysmal nocturnal hemoglobinuria]. (1993) (0)
Wnt Pathway Is Upregulated in Blood Cells From Patients with Paroxysmal Nocturnal Hemoglobinuria. (2009) (0)
[Complement system in host defense]. (2005) (0)
Advances of complement research and clinical application. PNH and complement controlling factors. (1995) (0)
1 Diagnosis and Management of Paroxysmal Nocturnal Hemoglobinuria : (2005) (0)
Organizations and Publications Adopting SNFG (2016) (0)
Porcine MCP gene promoter directs high level expression of HDAF (CD55) in transgenic mice (1998) (0)
[Progress on complement protein chemistry and the molecular mechanism of activation. Alternative complement pathway]. (1988) (0)
Inflammasome (PP-078) (2010) (0)
[Molecular abnormality of paroxysmal nocturnal hemoglobinuria]. (1994) (0)
The Clinical Course of PNH in the USA and in JAPAN (2003) (0)
[Contribution of Japanese researchers to progress in the field of hematology in the last 100 years: Pathogenic gene in paroxysmal nocturnal hemoglobinuria]. (2002) (0)
Establishment of a complement examination system for complement-related diseases by the Japanese Association for Complement Research (JACR) (2017) (0)
Comprehensive analysis of complement proteins and genes in thrombotic microangiopathy in Japan (2018) (0)
functions R effector γ GPI-anchor deficiency in myeloid cells causes impaired Fc (2013) (0)
207Screening patients with inherited GPI anchor deficiency to establish concept of the new disease (2012) (0)
Effect of trypsinization on the activity of human β 1H globulin (1982) (0)
Mechanism of autoinflammation in PIGT-PNH (2018) (0)
[Paroxysmal nocturnal hemoglobinuria: mechanism of clonal expansion]. (2005) (0)
Mouse GAA1 homologue is involved in transfeit of the GPI anchor to proteins (1997) (0)
Analysis of 3 Year Post Marketing Surveillance of Eculizumab in Japan (2014) (0)
of paroxysmal nocturnal Lting factor (2016) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Taroh Kinoshita?

Taroh Kinoshita is affiliated with the following schools:

Taroh Kinoshita's Academic­Influence.com Rankings

Taroh Kinoshita's Degrees

Similar Degrees You Can Earn

Why Is Taroh Kinoshita Influential?

Taroh Kinoshita's Published Works

Published Works

What Schools Are Affiliated With Taroh Kinoshita?

Taroh Kinoshita's AcademicInfluence.com Rankings